Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS
· Delayed Price · Currency is USD
30.50
-0.16 (-0.51%)
At close: May 2, 2025
BIOVF Revenue
Swedish Orphan Biovitrum AB had revenue of 6.47B SEK in the quarter ending March 31, 2025, with 3.34% growth. This brings the company's revenue in the last twelve months to 26.24B, up 13.38% year-over-year. In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B with 17.65% growth.
Revenue (ttm)
26.24B SEK
Revenue Growth
+13.38%
P/S Ratio
4.07
Revenue / Employee
14.53M SEK
Employees
1,806
Market Cap
10.64B USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
| Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
| Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
| Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
| Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| Silence Therapeutics | 27.70M |
Swedish Orphan Biovitrum AB News
- 14 days ago - Swedish Orphan Biovitrum AB (BIOVF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 6 weeks ago - Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. - Seeking Alpha
- 3 months ago - Swedish Orphan Biovitrum targets high single-digit growth in 2025 amid robust pipeline advancements - Seeking Alpha
- 3 months ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Swedish Orphan Biovitrum AB (publ) 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 7 months ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2024 Earnings Call Transcript - Seeking Alpha